Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q1 Loss of 1c

May 2, 2012 4:56 PM EDT
Get Alerts NBIX Hot Sheet
Trade NBIX Now!
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $10.84 million.

For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment